Table 5

Airway function and inflammatory markers in RSV versus control subjects with or without current asthma/RW at age 18 years

Current asthma/RWNo current asthma/RW
RSV (n=18)Controls (n=8)95% CI for differenceRSV (n=24)Controls (n=78)95% CI for difference
Resting
FEV1 (z-score)−0.64 (0.85)0.05 (0.77)−0.03 to 1.420.00 (0.91)0.11 (1.11)0.00 to 0.77*
FEV1/FVC (z-score)−0.89 (0.82)0.08 (1.37)0.09 to 1.86*−0.53 (0.86)−0.10 (1.00)0.24 to 0.97**
FEF25–75 (z-score)−0.89 (0.71)−0.06 (0.86)0.17 to 1.50*−0.38 (0.75)−0.05 (0.85)0.25 to 0.86***
LCI6.88 (0.63)6.89 (0.25)−0.46 to 0.496.44 (0.31)6.56 (0.43)−0.21 to 1.29
Challenge (DACh)
Fall in FEV1 (%)8.5 (0.0–37.8)7.5 (0.3–42.8)−5.5 to 11.53.6 (0.0–9.3)3.1 (0.0–22.1)−0.9 to 1.8
Post-bronchodilation
Rise in FEV1 (%)6.5 (0.0–10.2)2.5 (0.0–9.9)−0.3 to 6.35.4 (0.0–10.5)3.1 (0.0–10.4)−0.0 to 3.2**
FEV1 (z-score)−0.18 (0.79)0.25 (1.05)−0.34 to 1.200.41 (0.81)0.39 (1.15)−0.18 to 0.61
FEV1/FVC (z-score)−0.23 (0.83)0.48 (1.06)−0.09 to 1.500.11 (0.90)0.41 (0.95)0.11 to 0.80**
FEF25–75 (z-score)−0.29 (0.76)0.48 (0.72)0.11 to 1.43*0.19 (0.74)0.37 (0.84)0.11 to 0.69*
Inflammatory markers
FeNO (ppb)22 (6–84)15 (7–51)−7 to 2613 (6–54)12 (5–74)−3 to 3
Blood eosinophils (×109/l)0.33 (0.06–0.57)0.16 (0.04–0.31)0.01 to 0.27*0.16 (0.04–0.37)0.14 (0.01–0.79)−0.02 to 0.06
  • Data are shown as mean (SD) or median (range).

  • For normally distributed data differences between the two groups are shown with 95% CI for the mean values and for non-normally distributed data as the 95% CI for the medians.

  • * p<0.05

  • ** p<0.01

  • *** p<0.001.

  • DACh, isocapnic dry air hyperventilation challenge; FEF25–75, forced expiratory fraction at 25–75% forced vital capacity; FeNO, fraction exhaled nitric oxide; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; LCI, lung clearance index; ppb, parts per billion; RSV, respiratory syncytial virus; RW, recurrent wheeze.